Academic literature on the topic 'Sexual dysfunction, physiological – therapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Sexual dysfunction, physiological – therapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Sexual dysfunction, physiological – therapy"
Lukyantseva, G. V., and S. Y. Frank. "Possible applications of shock wave therapy in complex correction of sexual dysfunction in women." HEALTH OF WOMAN, no. 9(135) (November 30, 2018): 112–17. http://dx.doi.org/10.15574/hw.2018.135.112.
Full textBezkor, Mary F., and Angelo Canedo. "Physiological and psychological factors influencing sexual dysfunction in Multiple Sclerosis: Part 1." Sexuality and Disability 8, no. 3 (September 1987): 143–46. http://dx.doi.org/10.1007/bf01376984.
Full textStarc, Andrej. "Clinical hypnosis and female sexual dysfunction." Journal of applied health sciences 5, no. 1 (March 15, 2019): 105–11. http://dx.doi.org/10.24141/1/5/1/10.
Full textCohen, Seth D., Steven Mandel, and David B. Samadi. "Assessing Sexual Dysfunction Part 2: Female Sexual Dysfunction." Guides Newsletter 21, no. 3 (May 1, 2016): 3–8. http://dx.doi.org/10.1001/amaguidesnewsletters.2016.mayjun01.
Full textKhashukoeva, A. Z., M. V. Burdenko, A. V. Overko, T. E. Ryzhova, and M. S. Safonina. "Disorders of sexual function in postmenopausal patients." Meditsinskiy sovet = Medical Council, no. 3 (April 15, 2021): 106–11. http://dx.doi.org/10.21518/2079-701x-2021-3-106-111.
Full textSalehpour, Farzad, Mahsa Khademi, Farzan Vahedifard, and Paolo Cassano. "Transcranial Photobiomodulation Therapy for Sexual Dysfunction Associated with Depression or Induced by Antidepressant Medications." Photonics 9, no. 5 (May 11, 2022): 330. http://dx.doi.org/10.3390/photonics9050330.
Full textMattar, Citra Nurfarah, Yap Seng Chong, Lin Lin Su, Anupriya Aditya Agarwal, PC Wong, and Mahesh Choolani. "Care of Women in Menopause: Sexual Function, Dysfunction and Therapeutic Modalities." Annals of the Academy of Medicine, Singapore 37, no. 3 (March 15, 2008): 215–23. http://dx.doi.org/10.47102/annals-acadmedsg.v37n3p215.
Full textKim, Young-Joo, and Sung Dae Kim. "Approach to clinical diagnosis and treatment of erectile dysfunction of man." Journal of Medicine and Life Science 7, no. 2 (December 1, 2010): 1–6. http://dx.doi.org/10.22730/jmls.2010.7.2.1.
Full textFedorchenko, Yuliya, and Burhan Fatih Kocyigit. "PERSPECTIVES ON MALE AGING AND THERAPEUTIC IMPLICATIONS." Central Asian Journal of Medical Hypotheses and Ethics 4, no. 3 (December 29, 2023): 146–54. http://dx.doi.org/10.47316/cajmhe.2023.4.3.01.
Full textGamidov, S. I., O. Kh Tazhetdinov, A. A. Pavlovichev, A. Iu Popova, and R. A. Tkhagapsoeva. "Peculiarities of pathogenesis, diagnostics and treatment of erectile dysfunction in patients presenting with hypogonadism." Problems of Endocrinology 56, no. 5 (October 15, 2010): 33–42. http://dx.doi.org/10.14341/probl201056533-42.
Full textDissertations / Theses on the topic "Sexual dysfunction, physiological – therapy"
Schvartzman, Renata. "Intervenção fisioterapêutica em mulheres climatéricas com dispareunia : ensaio clínico randomizado." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/150667.
Full textBackground:Alterations in the pelvic floor during menopausal years, which are the result of hormonal and physical changes and of tissue aging itself, can lead to urinary and sexual dysfunction. The role of physical therapy in the treatment of urinary incontinence is well documented, but few studies have assessed its role in sexual dysfunction. Objective:To evaluate the effect of a physical therapy intervention on pain, sexual function, quality of life, and pelvic floor muscle function in climacteric women with dyspareunia. Methods:The present randomized controlled trial evaluated sexual function (Female Sexual Function Index), quality of life (Cervantes scale), pain (10-point visual analogue scale), and pelvic floor muscle function (electromyography and vaginal palpation/New PERFECT scale)before and after two treatments: the intervention group received pelvic floor thermal stimulation, myofascial release of pelvic floor muscle trigger points, and pelvic floor muscle training during five weekly sessions; in the control group, heat was applied to the lower back with myofascial release of abdominal diaphragm, piriformis, and iliopsoas muscles, with no involvement of pelvic floor muscles. The main outcome measure was the effect of the intervention on the degree of pain (dyspareunia). Secondary outcomes were post-treatment sexual function, quality of life, and pelvic floor muscle function. Results: Forty-two climacteric women with dyspareunia (mean age 51.3 ± 5.0 years) were studied. Pain scores in the intervention group decreased from 7.77±0.38 to 2.25±0.30; and in the control group, from 7.62±0.29 to 5.58±0.49, (statistically significant interaction effect (p<0.001). The intervention was associated with statistically significant improvement in pain scores, overall Female Sexual Function Index score, New PERFECT scores, and quality of life scores. Conclusion: The proposed physical therapy protocol was effective to improve pain, quality of life, sexual function, and pelvic floor muscle function in climacteric women with dyspareunia.
Lanza, Ana Helena Barbosa 1958. "Efeito de um programa de exercícios cinesioterapêuticos sobre a contratilidade do assoalho pélvico de mulheres com disfunção de orgasmo = avaliação eletromiográfica." [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308663.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-20T03:58:07Z (GMT). No. of bitstreams: 1 Lanza_AnaHelenaBarbosa_M.pdf: 1640627 bytes, checksum: c135a5857fcde47208c0a3c7f837045b (MD5) Previous issue date: 2011
Resumo: Objetivo. Avaliar o efeito de um programa supervisionado de cinesioterapia sobre a contratilidade do assoalho pélvico, e sua eventual correlação com a função orgásmica feminina. Sujeito e Métodos. Para este estudo clínico, prospectivo, randomizado, controlado e cego, foram inclusas 20 mulheres, com média de idade de 26,6 ± 6,1 anos, com queixa de falta de orgasmo durante a atividade sexual, as quais foram divididas aleatoriamente em dois grupos. Grupo 1 (G1): 10 mulheres; avaliadas quanto à função orgásmica e quanto à contratilidade muscular do assoalho pélvico; realizaram um protocolo de exercícios cinesioterapêuticos (12 sessões individuais, com duração de 30 minutos, duas vezes por semana), focado no fortalecimento muscular pélvico; e reavaliada quanto à função orgásmica e quanto à contratilidade muscular; Grupo 2 (G2): 10 mulheres; avaliadas quanto à função orgásmica e quanto à contratilidade muscular do assoalho pélvico; não realizaram o protocolo de exercícios cinesioterapêuticos; foram reavaliadas quanto à função orgásmica e quanto à contratilidade muscular simultaneamente às mulheres do G1, sendo denominado G2-Controle. Após uma semana, esse grupo realizou o mesmo protocolo de exercícios cinesioterapêuticos, foi reavaliado quanto à função orgásmica e quanto à contratilidade muscular, sendo denominado G2-Tratado. A função orgásmica foi avaliada por meio do domínio orgasmo do questionário validado para língua portuguesa Female Sexual Function Index (FSFI), e por meio do cálculo do Coeficiente de Capacidade Orgásmica (CCO). As avaliações da contratilidade muscular do assoalho pélvico foram realizadas por segundo pesquisador, o qual não tinha conhecimento do programa de tratamento, através de palpação digital (PD) e de eletromiografia de superficie (EMGs - com sensor intravaginal), enquanto que, o programa de exercícios cinesioterapêuticos foi elaborado e supervisionado por pesquisador, o qual não participou das avaliações da contratilidade muscular do assoalho pélvico. O questionário International Consultation on Incontinence Questionnaire Short-Form, validado para a língua portuguesa, foi aplicado na avaliação inicial, no intuito de verificar a coexistência da incontinência urinária. Para análise estatística foram utilizados o Teste t de Student, o Teste de Correlação de Pearson, e o Teste Regressão Linear Simples, com nível de significância de 5%. Resultados. Em contraste com o grupo controle (G2-Controle), os grupos que realizaram o programa de exercícios cinesioterapêuticos proposto (G1 e G2-Tratado) apresentaram aumento significativo na contratilidade do assoalho pélvico, tanto a avaliada pela PD (p<0,001), quanto a mensurada pela EMGs (p<0,001), e este aumento de contratilidade se correlacionou de forma significativa com a melhora no escore do domínio orgasmo do FSFI (p<0,001), e no escore do Coeficiente de Capacidade Orgásmica (p=0,001). Conclusão. O programa de exercícios cinesioterapêuticos proposto promoveu aumento na contratilidade do assoalho pélvico, com concomitante melhora da função orgásmica, indicando que essa abordagem terapêutica possa ser adjuvante no tratamento da disfunção orgásmica feminina
Abstract: Objective. Evaluate the effect of a protocol supervised of the kinesiotherapy on the contractility of the pelvic floor, and its possible correlation with female orgasmic function. Subjects and methods. For this clinical, prospective, randomized, controlled, blind study, were included 20 women, mean age 26.6 ± 6.1 years, complaining of lack of orgasm during sexual activity, which were randomly divided into two groups. Group 1 (G1): 10 women, evaluated for orgasmic function and on the contractility of the pelvic floor, made a kinesiotherapy protocol (12 sessions, lasting 30 minutes, twice a week), focused on muscle strengthening, and reassessed as the orgasmic function and the contractility of the pelvic floor; Group 2 (G2): 10 women, evaluated for orgasmic function and on the contractility of the pelvic floor, did not realize the kinesiotherapy protocol, were reassessed on the orgasmic function and on the contractility of the pelvic floor while the women in the G1, and called G2- Control. After one week, this group received the same kinesiotherapy protocol, was reassessed as the orgasmic function and on the contractility of the pelvic floor, and called G2- Treaty. Orgasmic function was assessed using the orgasm domain of the validated questionnaire to portuguese Female Sexual Function Index (FSFI), and by calculating the Coefficient of Orgasmic Capacity (COC). The assessments of the pelvic floor muscle contractility were performed by the second researcher, which was not aware of the treatment program, by digital palpation (DP) and surface electromyography (sEMG - with intravaginal sensor), while kinesiotherapy program was drafted and supervised by a researcher no involved in the assessments of contractility of the pelvic floor. The International Consultation on Incontinence Questionnaire, validated for the portuguese language was used in the initial assessment, in order to verify the coexistence of urinary incontinence. Statistical analysis was performed using the Student t Test, the Pearson Correlation Test, and the Simple Linear Regression Test, with a significance level of 5%. Results. In contrast to the control group xvi (G2-control), groups that performed kinesiotherapy (G1 and G2-Treaty) showed a significant increase in contractility of the pelvic floor, assessed by PD (p <0,001), and measured by EMG (p <0.001), and this increase in contractility was positively correlated with the improvement in the orgasm domain score of the FSFI (p <0,001), and the score of the Coefficient Orgasmic Capacity (p = 0,001). Conclusion. The kinesiotherapy exercises program promoted increase in contractility of the pelvic floor, with concomitant improvement in orgasmic function, indicating that this therapeutic approach could be an adjunct in the treatment of female orgasmic dysfunction
Mestrado
Fisiopatologia Cirúrgica
Mestre em Ciências da Cirurgia
Nunes, Luciana Vargas Alves [UNIFESP]. "A acurácia da Escala de Experiência Sexual do Arizona (ASEX) para identificar disfunção sexual em pacientes do espectro da esquizofrenia." Universidade Federal de São Paulo (UNIFESP), 2009. http://repositorio.unifesp.br/handle/11600/8805.
Full textContexto: a disfunção sexual é frequente entre pacientes com esquizofrenia, sendo relatada como um dos mais incômodos efeitos adversos dos antipsicóticos e esta diretamente relacionada com adesão ao tratamento. Objetivo: a) avaliar a frequência da disfunção sexual em uma amostra de pacientes do espectro da esquizofrenia em tratamento com antipsicóticos; b) investigar 0 efeito dos diferentes antipsicóticos na função sexual; e c) avaliar a acurácia da Escala de Experiência Sexual do Arizona (AS EX) para identificar disfunção sexual. Método: pacientes ambulatoriais com esquizofrenia ou transtorno esquizoafetivo foram entrevistados através de questionários: ASEX e Escala Dickson-Glazer (DGSFi) para avaliação do funcionamento sexual, em uma única entrevista. Resultados: 137 pacientes foram entrevistados. A sensibilidade e especificidade da ASEX em relação a DGSFi foram: 80.8% ( 95% IC= 70.0%-88.5%) e 88.1 % (95% IC=76.5%-94.7%), e a taxa de classificação incorreta foi 9.5%. A curva ROC comparando a pontuação da ASEX e DGSFi revelou valor de 0.93 (IC=0.879¬0.970) com 0 ponto de corte da ASEX encontrando sendo 14/15. A disfunção sexual foi mais alta entre as mulheres (79.2%) do que nos homens (33.3%) (X2=27.41, gl=1, p<0.001). Conclusão: pacientes em tratamento com antipsicóticos mostraram alta frequência de queixas sexuais e ASEX provou ser um instrumento eficaz para identificar disfunção sexual em amostra de pacientes ambulatoriais do espectro da esquizofrenia. Mulheres mostraram frequência mais alta de disfunção, e desejo sexual e habilidade para alcançar orgasmo foram áreas mais afetadas. 0 uso de antipsicóticos, principal mente 0 uso de combinações, foi associado com piora do funcionamento sexual..
Background: sexual dysfunction is frequent in patients with schizophrenia, it is reported as one of the most distressing antipsychotic’s adverse effects and it is directly related to treatment compliance. Objective: a) to assess the frequency of sexual dysfunction in a sample of outpatients with schizophrenia and schizoaffective disorder under antipsychotic therapy; b) to investigate the effect of different antipsychotics on sexual function; and c) to evaluate the accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction. Method: Outpatients with schizophrenia or schizoaffective disorder were asked to fulfill both the ASEX and the Dickson Glazer Scale for the Assessment of Sexual Functioning Inventory (DGSFi) at a single interview. Results: 137 patients were interwied. The sensitivity and specificity of the ASEX in relation to DGSFi were: 80.8%, (95% CI= 70.0%-88.5%) and 88.1% (95% CI= 76.5%-94.7%), and the misclassification rate was 9.5%. The ROC curve comparing the ASEX and the DGSFi scores revealed a value of 0.93 (CI= 0.879-0.970), with the optimum cut-off point of ASEX being 14/15. Sexual dysfunction measured was higher in females (79.2%) than in males (33.3%) (2 = 27.41, d.f.=1, p<0.001). Discussion: Patients under antipsychotic treatment showed a high level of sexual complaints, and the ASEX proved to be an accurate instrument to identify sexual dysfunction in an outpatient sample of patients with schizophrenia spectrum. Females showed a higher frequency of sexual dysfunctions and sexual drive and ability to reach orgasm were the most affected areas. The use of antipsychotics, especially the combinations, was more likely to impair sexual functioning.
TEDE
BV UNIFESP: Teses e dissertações
Fawcett, David. "The Influence of Profession and Therapy Type for the Cost Effective Treatment of Sexual Dysfunction." BYU ScholarsArchive, 2011. https://scholarsarchive.byu.edu/etd/3017.
Full textRegadas, Rommel Prata. "Efeito do creme de jambu (acmella oleracea) sobre a funÃÃo sexual masculina e feminina." Universidade Federal do CearÃ, 2008. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=2582.
Full textO Jambu (Spilanthes oleracea ou Spilanthes acmella var oleracea ou Acnella oleracea) à uma planta tÃpica da regiÃo norte do Brasil, mais precisamente do ParÃ. à utilizado na culinÃria paraense, fazendo parte do prato de peixes como o TacacÃ, o Pato no Tucupi. AlÃm da utilizaÃÃo na culinÃria, tem tido outras aplicaÃÃes, principalmente como analgÃsica, anti-inflamatÃria e antifÃngica. Recentemente, tem sido utilizado como estimulante sexual em mulheres. Segundo a cultura popular, o aumento da excitaÃÃo feminina decorreria de uma atividade contrÃtil (aumento do peristaltismo) na vulva. Entretanto, nenhum estudo bem conduzido foi publicado na literatura mÃdica para confirmar se isso à realmente verdade. O presente estudo teve como objetivo avaliar se a pomada de Jambu realmente aumenta a excitaÃÃo e o desejo sexual feminino; se ocasiona algum impacto sobre o desejo e a satisfaÃÃo sexual masculina e, por fim, observar a sua seguranÃa e tolerabilidade. Dois ensaios clÃnicos randomizados, cruzados e placebo-controlados, foram realizados ao mesmo tempo: um para avaliar os homens que utilizaram o creme e o placebo e outro para avaliar as mulheres. Vinte e dois casais participaram do estudo. Utilizaram, durante as relaÃÃes sexuais, o creme de JAMBU e o placebo. Foram avaliados separadamente, por questionÃrios auto-aplicÃveis, antes e apÃs a utilizaÃÃo de cada pomada. Os questionÃrios utilizados foram o Ãndice Internacional de FunÃÃo ErÃtil (IIEF) e o Ãndice de Funcionamento Sexual Feminino (FSFI). A mÃdia de idade foi de 43,3 anos para os homens e de 40,5 anos para as mulheres. Verificou-se que, apÃs o tratamento, o desejo e a satisfaÃÃo sexual mensurados no grupo Jambu foram significantemente maiores que o observado no grupo Placebo, nos homens (P = 0,0008 e P = 0,0006, respectivamente). O desejo e a excitaÃÃo sexual na mulher mensurados no grupo Jambu tambÃm foram significantemente maiores que o observado no grupo Placebo (P = 0,0006 e P = 0,0005, respectivamente). Igualmente, apenas no grupo Jambu, houve um aumento significante sobre o desejo e a satisfaÃÃo sexual nos homens e sobre o desejo e a excitaÃÃo nas mulheres, apÃs o tratamento quando comparado aos valores basais (P = 0,0002 e P = 0,0003) e (P = 0,0001 e P = 0,0008, respectivamente). O mesmo nÃo ocorreu com o placebo. NÃo foi constatada diferenÃa estatisticamente significante em relaÃÃo à alteraÃÃo no tempo ejaculatÃrio (P = 0,7768) entre os grupos placebo e Jambu. TambÃm nÃo foi constatada diferenÃa estatisticamente significante em relaÃÃo à dor ou desconforto apÃs a utilizaÃÃo das pomadas, tanto no grupo masculino quanto no grupo feminino, (P = 0,7728 e P = 1,0000) entre os dois grupos. Conclui-se que o creme de Jambu (Acmella oleracea) aumentou a excitaÃÃo e o desejo sexual feminino e o desejo e a satisfaÃÃo sexual masculina durante atividade sexual, quando comparada ao placebo. NÃo houve alteraÃÃo no tempo ejaculatÃrio dos pacientes que utilizaram o creme. Os efeitos colaterais foram discretos e cessaram apÃs a sua remoÃÃo.
The toothache plant (Spilanthes oleracea or Spilanthes acmella oleracea or simply Acmella oleracea) is a well-known herb in Northern Brazil, especially in ParÃ, where it is referred to as jambu. Though commonly used in the local cuisine in dishes such as tacacà and pato-no-tucupi, it is also widely used to prepare analgesic, antiinflammatory and antifungal medications. Extracts of this plant have recently become popular as a topical sexual stimulant for women. The active substance in the herb, spilanthol, is believed to contract the vulva, but so far no medical study has been published confirming this. In the present randomized, double-blind, placebo-controlled crossover clinical study a cream was prepared from extracts of the toothache plant and tested with regard to its effect on female sexual desire and excitation and male sexual desire and satisfaction and ejaculation time, along with safety and tolerability. Twenty-two blinded couples used cream with and without extract of A. oleracea during two periods of 4 weeks. The participants were aged 43.3 years (men) and 40.5 years (women) on the average and were evaluated individually using self-reported questionnaires (the International Index of Erectile Function and The Female Sexual Function Index) before and after the use of each cream. Compared to placebo, male sexual desire and satisfaction (p=0.0008 and p=0.0006, respectively) and female sexual desire and excitation (p=0.0006 and p=0.0005, respectively) were significantly greater when couples were using the extract. Likewise, male sexual desire and satisfaction (p=0.0002 and p=0.0003, respectively) and female sexual desire and excitation (p=0.0001 and p=0.0008, respectively) only increased in relation to baseline values when couples were using extract. No significant differences were observed between extract and placebo with regard to ejaculation time (p=0.7768), nor with regard to pain and discomfort after intercourse, as reported by both genders (p=0.7728 and p=1.0000, respectively). It may be concluded that cream prepared from extracts of the toothache plant increased female sexual desire and excitation and male sexual desire and satisfaction during intercourse compared to placebo and baseline, without affecting ejaculation time. Side effects were negligible and subsided after completion of treatment.
Hagey, Derek Willis. "Collaborative treatment of erectile dysfunction: thoughts from the membership of the Sexual Medicine Society of North America." Diss., Kansas State University, 2012. http://hdl.handle.net/2097/13791.
Full textDepartment of Family Studies and Human Services
Sandra Stith
Recent years have seen a rise in the medicalization of treatments for erectile dysfunction (ED). While there has been a divide between the medical and psychological communities, some have called for a more collaborative relationship. Little research has been done on the collaboration between medical professionals and psychotherapists in treating ED. This study seeks to increase current knowledge about medical professionals’ referral practices and communication post-referral. An online survey was developed and distributed to the members of the Sexual Medicine Society of North America (SMSNA) (N = 541). Survey questions inquired as to the factors that increased participants’ willingness to refer ED patients, the form of communication participants currently desire to have with psychotherapists and the participants’ desired level of communication with psychotherapists to whom they might refer. Less than ten percent of the medical professionals invited to participate in the study completed the survey (n=50). Those who did complete the survey were primarily male, specialized in urology and practiced in the U.S. Almost half the respondents were employed in an academic setting while just over half of respondents worked in hospital-based, group, or solo practices. Just over half of the survey participants practiced in urban areas. Although the number of medical professionals who completed the survey was small, findings indicated that those who completed a sexual medicine fellowship and who had a larger percentage of their patient population being seen for ED were more likely to refer patients to psychotherapists. Participants who have referred ED patients to psychotherapists reported little-to-no communication between them and the psychotherapists to whom they refer. The study participants expressed a desire to refer patients to psychotherapists who are experienced in working with both sexual and couples issues. Questions about the desires and experiences of medical professionals who have not referred to psychotherapists were not able to be answered because of the limited number of these individuals in the data set. Although the number of participants who completed the survey limits the generalizability of the data, this study demonstrates that most medical professionals who responded to the survey are willing to refer ED patients to psychotherapists.
Wilson, Jerika. "Who’s Coming to Sex Therapy? Exploring Black Women’s Willingness to Seek Treatment for Sexual Problems/Dysfunctions." University of Cincinnati / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1479816476417109.
Full textSouto, Sophia Consuelo 1983. "Impacto da aplicação topica do gel doador de oxido nitrico no fluxo sanguineo clitoridiano, avaliado pelo ultra-som Doppler." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311594.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-11T15:13:42Z (GMT). No. of bitstreams: 1 Souto_SophiaConsuelo_M.pdf: 4211847 bytes, checksum: 42d0aabe09e9a27f66e06e5f8b6d381f (MD5) Previous issue date: 2008
Resumo: Introdução: O sexo é parte do cotidiano das pessoas não estando limitado à concepção. Diversos fatores podem inibir a resposta sexual da mulher, tanto de forma transitória como prolongada. A resposta sexual sofre efeitos da: idade, tabaco, colesterol, hipertensão e diabetes. É uma condição multifatorial, com componentes anatômicos, fisiológicos, médicos, psicológicos e sociais. (Wyman JF; et al, 1987) O aumento do fluxo sanguíneo clitoridiano ocorre em decorrência do estímulo sexual, sendo parte da resposta sexual feminina. (Levin RJ, 1980) Sendo, portanto, uma boa forma de avaliar um método de tratamento para disfunção sexual feminina. O óxido nítrico (NO) e peptídeos vasoativos intestinais estão implicados no ingurgitamento de tecido clitoridiano após estimulação sexual. O NO constitui uma das menores e mais simples moléculas biossintetizadas, é um radical livre, gasoso, inorgânico, incolor, que possui sete elétrons do nitrogênio e oito do oxigênio, tendo um elétron de oxigênio desemparelhado. (Beckman JS & Koppenol WH, 1996) Objetivo Avaliar através do exame de ultra-sonografia Doppler se a aplicação tópica de um gel doador de óxido nítrico aumentaria o fluxo sanguíneo clitoridiano de mulheres normais. Materiais e Métodos No presente estudo, foram avaliadas vinte mulheres normais das quais passaram por exame de ultra-sonografia Doppler na artéria clitoridiana, comparando o fluxo sanguíneo normal e o fluxo sanguíneo com a utilização do gel doador de óxido nítrico. A analise hemodinâmíca constou de: velocidade sistólica de pico, velocidade diastólica e índice de resistência do vaso. Resultados: Na análise estatística verificou-se diferença significância para todos os parâmetros estudados (p < 0,05). A velocidade sistólíca mediana inicial foi de 104 e após aplicação do gel doador de óxido nítrico foi de 109 (p=0,002). A velocidade diastólica mediana inicial foi de 107 e após aplicação do gel passou a 106 (p=0,043) e a resistência mediana inicial foi de 105 e após aplicação do gel tornou-se 107 (p=0,005). Conclusão: Concluímos que a utilização tópica deste gel doador de óxido nítrico foi eficaz para aumentar o fluxo sanguíneo na região clitoridiana
Abstract: Introduction Sex is a part of the daily life of people and it is not just limited to conception. Different factors may inhibit female's sexual response, in a transitory or prolonged way. The sexual response is affected by age, tobacco, cholesterol, hypertension and diabetes. It is a multifactor condition, with anatomical, physiological, medical, psychological and social factors. (Wyman JF; et al, 1987) The increase of blood flow in the clitoris is due to sexual stimulation, being a part of the female's sexual response. (Levin RJ, 1980) That makes it a good way to asses a treatment for female sexual dysfunction. The nitric oxide (NO) and intestinal vase active peptides are involved in the ingurgitation of clitoridean tissue after sexual stimulation. The nitric oxide is one of the smallest and most simple biosynthesized molecules, and it is a gaseous, inorganic, colorless free radical, with seven electrons from nitrogen and eight from oxygen, and one oxygen electron is uneven. (Beckman JS & Koppenol WH, 1996) Objective Evaluate through the Doppler ultra-sound if the topic use of a nitric oxide donor gel would increase the blood flow in the clitoris of healthy women. Materials and method In this study we evaluated twenty healthy women who underwent ultrasound of the clitoris artery, comparing the normal blood flow and the flow with the use of the gel. The hemodynamic analysis considered: systolic peak speed, diastolic speed and vase resistance index. Results In the statistical analysis we found significant statistical differences in all the parameters measured (p < 0,05). The mean initial systolic speed was 104 and after the gel use it was 109 (p=0,002). The mean initial diastolic speed was 107 and with Abstract the gel it was 106 (p=0,043) and the mean initial resistance was 105 and after the use of the gel it was 107 (p=0,005). Conclusion The use of the topic gel proved to be effective to increase the blood flow in the area of the clitoris
Mestrado
Pesquisa Experimental
Mestre em Cirurgia
Castelo, Ana Rita Pimentel. "Application of Female Sexual Function Index in mastectomized and non-mastectomized women: a comparative study." Universidade Federal do CearÃ, 2014. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=18456.
Full textO cÃncer de mama à um problema de saÃde pÃblica no mundo, pois se estima que mais de 1 milhÃo de mulheres sejam diagnosticadas com a doenÃa a cada ano. à o mais frequente em todas as regiÃes do paÃs, exceto na RegiÃo Norte. Com isso, a mulher mastectomizada vivencia um momento de fragilidade emocional e sexual, jà que a mama, sÃmbolo de feminilidade, exerce importante papel no exercÃcio da sexualidade. Os objetivos deste estudo foram avaliar a disfunÃÃo sexual feminina em um grupo de mulheres mastectomizadas e nÃo mastectomizadas a partir da aplicaÃÃo do Female Sexual Function Index; verificar a incidÃncia da disfunÃÃo sexual feminina entre as mulheres mastectomizadas e das mulheres nÃo mastectomizadas; e verificar a correlaÃÃo entre os escores da FSFI e os antecedentes pessoais, clÃnicos, queixas e sintomas relacionados à sexualidade nos dois grupos avaliados. Desenvolveu-se um estudo transversal, comparativo realizado no Centro Regional Integrado de Oncologia (CRIO), na AssociaÃÃo Cearense das Mulheres Mastectomizadas - Toque de Vida e no Centro de Desenvolvimento Familiar (CEDEFAM). A coleta de dados ocorreu no perÃodo de janeiro a fevereiro de 2014. Sendo a amostra composta por dois grupos: 73 mulheres mastectomizadas e 62 mulheres sem diagnÃstico de cÃncer de mama. Foi aplicado a Female Sexual Function Index (FSFI), e um questionÃrio socioeconÃmico e gineco-obstÃtrico. Foi realizada anÃlise estatÃstica descritiva (frequÃncias absoluta e relativa, mÃdia e desvio padrÃo) e para se testar as mÃdias foi aplicado o teste F de Snedecor (ANOVA). A maioria das mulheres mastectomizadas investigadas concentrou-se na faixa etÃria acima de 42 anos (75,3%), enquanto as mulheres nÃo mastectomizadas concentrou-se na faixa etÃria de 18 a 36 anos (66,1%). Ao analisarmos a prevalÃncia de disfunÃÃo sexual neste estudo observa-se que foi de 55,6%. Foi possÃvel observar que no grupo de mulheres com CA de mama somente o domÃnio lubrificaÃÃo apresentou significÃncia estatÃstica quando comparado com a idade. Quanto Ãs relaÃÃes sexuais mensais no grupo das mulheres mastectomizadas, percebe-se que houve correlaÃÃo estatisticamente significante em todos os domÃnios da escala FSFI, exceto no domÃnio dor (p>0,05). Apresentando o teste r positivo, isso demonstra que quanto mais relaÃÃes sexuais essas mulheres tiverem maior serà o desejo, a excitaÃÃo, a lubrificaÃÃo, o orgasmo e a satisfaÃÃo. O alfa de Cronbach da FSFI foi de 0,95 indicando alta consistÃncia interna e a validade de construto foi analisada por meio do coeficiente de correlaÃÃo linear de Pearson (p=0,0001), demonstrando correlaÃÃo entre os domÃnios da escala. Logo, podemos concluir que o enfermeiro que assiste a mulher de um modo geral deve prestar assistÃncia qualificada para que todos os obstÃculos sejam minimizados para favorecer a qualidade de vida e sexual.
Marino, Flávia Fairbanks Lima de Oliveira. "Aspectos da sexualidade em mulheres com endometriose." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-06122016-155542/.
Full textINTRODUCTION: Endometriosis is a disease that negatively affects several aspects of a woman\'s life, including sexual function. The main symptoms of endometriosis - pain and infertility - are directly related to losses of sexual function, but which specific aspects of sexual function remains unclear. STUDY DESIGN: cross-sectional. SETTING: The outpatient clinics of the Endometriosis and General Gynecology Services of the Hospital das Clínicas of the USP School of Medicine and the Vila Regina (São Paulo) Municipal Primary Care Clinic. PATIENTS: 1001 women divided into two groups, according to the presence or absence of endometriosis. INTERVENTIONS: We assessed sexual function, anxiety and depression of patients and correlated these findings with symptoms, locations and types of endometriosis and the affected domains of sexual function. We recruited 1001 women seen consecutively between April 2013 and April 2015; 18 completed the forms incorrectly. 294 women (29.9%) were excluded due to severe anxiety and depression. 106 patients had symptoms that could have any relation to endometriosis, so they were also excluded. The final cohort was composed of 254 patients with endometriosis and 329 patients without the disease. Sexual function score was assessed using the Female Sexual Quotient (QSF); Beck inventories were used to assess anxiety and depression. The data were tabulated and analyzed by applying the appropriate statistical tests (Chi-square, Student\'s t and Mann-Whitney). RESULTS: Our results showed that patients with endometriosis were affected in all phases of sexual response, with statistical significance in three of them: sexual arousal, genital-pelvic pain/ penetration and orgasm/ sexual satisfaction. In the overall assessment, 43.3% of patients with endometriosis had sexual dysfunction, while the population without endometriosis sexual dysfunction occurred in 17.6% of women. Endometriosis conferred a relative risk of 52% (OR = 1.52) for the occurrence of sexual dysfunctions. CONCLUSION: Patients with endometriosis have double the sexual dysfunction as compared to women without the disease
Books on the topic "Sexual dysfunction, physiological – therapy"
Richard, Balon, ed. Sexual dysfunction. Basel: Karger, 2008.
Find full textMaggi, M. Hormonal therapy for male sexual dysfunction. Chichester, West Sussex, UK: Wiley-Blackwell, 2012.
Find full textZaslau, Stanley. Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.
Find full text1944-, Charlton Randolph S., and Yalom Irvin D. 1931-, eds. Treating sexual disorders. San Francisco, Calif: Jossy-Bass Publishers, 1997.
Find full text1944-, Charlton Randolph S., and Yalom Irvin D. 1931-, eds. Treating sexual disorders. San Francisco: Jossy-Bass Publishers, 1997.
Find full textHartman, William E. Treatment of sexual dysfunction: A basic approach. Northvale, N.J: Jason Aronson, 1994.
Find full textWincze, John P. Enhancing sexuality: A problem-solving approach to treating dysfunction : workbook. 2nd ed. Oxford: Oxford University Press, 2009.
Find full textWincze, John P. Enhancing sexuality: A problem-solving approach to treating dysfunction : therapist guide. 2nd ed. Oxford: Oxford University Press, 2009.
Find full text1948-, Weeks Gerald R., and Sendak Shelley K, eds. A clinician's guide to systemic sex therapy. New York, NY: Brunner-Routledge, 2009.
Find full textZaslau, Stanley. Dx/Rx: Sexual dysfunction in men and women. Sudbury, Mass: Jones & Bartlett Learning, 2012.
Find full textBook chapters on the topic "Sexual dysfunction, physiological – therapy"
LoPiccolo, Joseph. "Sexual Dysfunction." In International Handbook of Behavior Modification and Therapy, 547–64. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0523-1_26.
Full textGarcia, Francisco J., Eric Chung, and Gerald Brock. "Drug therapy for erectile dysfunction." In Male Sexual Dysfunction, 172–93. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch19.
Full textGregory, Angela. "Psychosexual therapy for male sexual dysfunction." In Male Sexual Dysfunction, 133–42. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch16.
Full textRees, Rowland, and Victoria Dawson. "Non-surgical therapy for Peyronie's disease." In Male Sexual Dysfunction, 229–35. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch24.
Full textRidout, Ashley, Mark Emberton, and Caroline Moore. "Sexual dysfunction and prostate cancer therapy." In Male Sexual Dysfunction, 302–13. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch32.
Full textAl-Shaiji, Tariq F., Eric Chung, and Gerald B. Brock. "Erectile Dysfunction: Pharmacological Therapy." In Cancer and Sexual Health, 675–96. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_44.
Full textMaruccia, Serena, and Angela Maurizi. "Anatomical and Physiological Description of Women’s Sexuality." In Female Sexual Function and Dysfunction, 7–25. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5_2.
Full textBanner, Linda L. "Sex Therapy in Female Sexual Dysfunction." In Cancer and Sexual Health, 649–56. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_42.
Full textAlthof, Stanley E., and Rachel B. Needle. "Sex Therapy in Male Sexual Dysfunction." In Cancer and Sexual Health, 731–38. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_48.
Full textRajfer, Jacob, Nestor Gonzalez-Cadavid, and Mark Jalkut. "Peyronie’s Disease: Pathophysiology and Medical Therapy." In Atlas of Male Sexual Dysfunction, 167–81. London: Current Medicine Group, 2004. http://dx.doi.org/10.1007/978-1-4613-1087-7_11.
Full textConference papers on the topic "Sexual dysfunction, physiological – therapy"
Buttros, Daniel, Caroline Nakano Vitorino, Heloisa Maria de Luca Vespoli, Rafaela Caroline de Souza, and Eliana Aguiar Petri Nahás. "Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1037.
Full textKumalasari, Ratna Dewi, idik Gunawan Tamtomo, and Hanung Prasetya. "Hypnosis and Sexual Arousal: A Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.41.
Full textFrechette, D., L. Paquet, S. Verma, M. Clemons, P. Wheatley-Price, SZ Gertler, X. Song, N. Graham, and S. Dent. "PD04-04: Sexual Dysfunction in Women with Early Stage Breast Cancer on Endocrine Therapy: Encouraging Results from a Prospective Study." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-pd04-04.
Full textBitenc Zore, Sara, Domen Vozel, and Saba Battelino. "Facial Nerve Reconstructive Surgery in Otorhinolaryngology and its Enhancement by Platelet- and Extracellular Vesicle-Rich Plasma Therapy." In Socratic Lectures 7. University of Lubljana Press, 2022. http://dx.doi.org/10.55295/psl.2022.d5.
Full textSadeghi Bahmani, D., V. Farnia, M. Alikhani, F. Tatari, E. Holsboer-Trachsler, and S. Brand. "Rosa Damascena Oil improved methadone-induced sexual dysfunction and happiness in female patients with opium use disorder under methadone maintenance therapy – results from a double-blind, randomized, and placebo-controlled trial." In Abstracts of the 30th Symposium of the AGNP. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1606431.
Full textTrivellato, Stella de Angelis, Joao Lucas Gomes Salgado, Hendrick Henrique Fernandes Gramasco, Guilherme Drumond Jardini Anastacio, Daniel Fabiano Barbosa Dos Santos, Laura Cardia Gomes Lopes, and Júlio Cesar dos Santos Moreira. "Thoracolumbar progressive myelopathy due to extra-dural arteriovenous fistula." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.223.
Full textReports on the topic "Sexual dysfunction, physiological – therapy"
Duan, Liyang, Xiaoyu Li, Haiqin Rong, Haiju Sun, Yajun Zhang, Shipeng Song, Jianqiao Fang, and Yongqiang Sun. Scalp acupuncture for Post-stroke depression: A protocol for a systematic review and meta-analysis of randomized controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0059.
Full textDahm, Philipp, Michelle Brasure, Elizabeth Ester, Eric J. Linskens, Roderick MacDonald, Victoria A. Nelson, Charles Ryan, et al. Therapies for Clinically Localized Prostate Cancer. Agency for Healthcare Research and Quality (AHRQ), September 2020. http://dx.doi.org/10.23970/ahrqepccer230.
Full text